drugset / Trial / NCT00003108

Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer

NCT00003108

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of cisplatin plus bryostatin 1 in treating patients who have advanced cancer.

Timeline

Start
1997-10
Primary completion
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified
Subject bryostatin 1 Small molecule